Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN144,32144,61,20
Msft-1,18
Nokia-1,68
IBM-1,41
Mercedes-Benz Group AG48,3550,75
PFE-1,61
09.06.2026 1:38:52
Indexy online
AD Index online
select
AD Index online
 

  • 08.06.2026
USANA Hlth Sci (USNA.K, NY Consolidated)
Závěr k 8.6.2026 Změna (%) Změna (USD) Objem obchodů (USD)
18,70 3,72 0,67 1 211 000
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiUSANA Health Sciences Inc
TickerUSNA
Kmenové akcie:Ordinary Shares
RICUSNA.K
ISIN-
Poslední známé roční výsledky03.01.2026
Poslední známé čtvrtletní výsledky04.04.2026
Počet zaměstnanců k 03.01.2026 1 570
Akcie v oběhu k 08.05.2026 18 463 011
MěnaUSD
Kontaktní informace
Ulice3838 West Parkway Blvd.
MěstoSALT LAKE CITY
PSČ84120-6336
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 019 547 100
Fax18019569486

Business Summary: USANA Health Sciences, Inc. and subsidiaries is a global nutrition, personal health and wellness company that develops and manufactures nutritional supplements, functional foods and personal care products. Its segments include Core nutritional and Hiya direct-to-consumer. The Core nutritional segment develops and manufactures science-based nutritional, personal care and skincare products with a primary focus on promoting long-term health and wellness in various geographic markets worldwide that are distributed through the core nutritional channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the United States that are distributed through the direct-to-consumer channel. Its product line includes USANA Nutritionals Optimizers, Essentials/CellSentials, Foods, Personal care and Skincare, and All other. USANA Nutritionals Optimizers products include Proflavanol, CoQuinone 30, and BiOmega-3.
Financial Summary: BRIEF: For the three months ended 04 April 2026, USANA Health Sciences Inc revenues increased less than 1% to $250.2M. Net income decreased 20% to $7.5M. Revenues reflect Americas and Europe segment increase of 6% to $80.9M, Greater China segment increase of 4% to $123.3M, also reflect Southeast Asia Pacific segment decrease of 14% to $30.7M, North Asia segment decrease of 19% to $15.4M.
Odvětvová klasifikace
TRBC2009Personal Products
TRBC2012Special Foods & Wellbeing Products
RBSS2004Personal Products
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSMedicinal and Botanical Manufacturing
NAICSPharmaceutical Preparation Manufacturing
NAICSToilet Preparation Manufacturing
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICS2007Medicinal & Botanical Mfg
NAICS2007Pharmaceutical Preparation Mfg
NAICS2007Toilet Preparation Manufacturing
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Medicinal and Botanical Manufacturing
NAICS1997Pharmaceutical Preparation Manufacturing
NAICS1997Toilet Preparation Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICMedicinals And Botanicals
SICMedicinals And Botanicals
SICPharmaceutical Preparations
SICToilet Preparations
SICCommercial Physical Research



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Executive Chairman of the Board, Chief Executive OfficerKevin Guest6308.01.2026
Chief Financial OfficerG. Hekking5602.05.201710.05.2011
Chief Operating OfficerWalter Noot60
Chief People OfficerPaul Jones6314.12.2012
Chief Scientific OfficerKathryn Armstrong4522.01.202522.01.2025
Chief Legal Officer, General Counsel and Corporate SecretaryP. Joshua Foukas50
Chief Commercial OfficerBrent Neidig42